About Utah Kidney Research Institute
Clinical Trials at Utah Kidney Research Institute
During the past decade, Utah Kidney Research Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Utah Kidney Research Institute" #1 sponsor was "ChemoCentryx" with 2 trials, followed by "Genzyme, a Sanofi Company" with 1 trials
sponsored, "Goldfinch Bio, Inc." with 1 trials sponsored, "Palladio Biosciences" with 1 trials sponsored and "Transplant Genomics, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Utah Kidney Research Institute"
#1 collaborator was "Centessa Pharmaceuticals plc" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Utah Kidney Research Institute
According to Clinical.Site data, the most researched conditions in "Utah Kidney Research Institute" are
"Focal Segmental Glomerulosclerosis" (2 trials), "ADPKD" (1 trials), "Alport Syndrome" (1 trials), "Autosomal Dominant Polycystic Kidney" (1 trials) and "Diabetes Complications" (1 trials). Many other conditions were trialed in "Utah Kidney Research Institute" in a lesser frequency.
Clinical Trials Intervention Types at Utah Kidney Research Institute
Most popular intervention types in "Utah Kidney Research Institute" are "Drug" (5 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "CCX140-B" (2 trials), "GFB-887" (1 trials), "Lixivaptan" (1 trials) and "Patients monitored with TruGraf and TRAC testing" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Utah Kidney Research Institute
The vast majority of trials in "Utah Kidney Research Institute" are
6 trials for "All" genders.
Clinical Trials Status at Utah Kidney Research Institute
Currently, there are NaN active trials in "Utah Kidney Research Institute".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Utah Kidney Research Institute,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Utah Kidney Research Institute, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".